BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Storer TW, Miciek R, Travison TG. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian J Androl. 2012;14:204-221. [PMID: 22367184 DOI: 10.1038/aja.2011.104] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Owen PJ, Daly RM, Dalla Via J, Mundell NL, Livingston PM, Rantalainen T, Fraser SF. Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia? Calcif Tissue Int 2019;105:403-11. [DOI: 10.1007/s00223-019-00586-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Hilton EN, Lundberg TR. Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage. Sports Med 2021;51:199-214. [PMID: 33289906 DOI: 10.1007/s40279-020-01389-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
3 Girard D, Marino FE, Cannon J. Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer. Clin Physiol Funct Imaging 2014;34:209-17. [DOI: 10.1111/cpf.12084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tapper J, Arver S, Pencina KM, Martling A, Blomqvist L, Buchli C, Li Z, Gagliano-Jucá T, Travison TG, Huang G, Storer TW, Bhasin S, Basaria S. Muscles of the trunk and pelvis are responsive to testosterone administration: data from testosterone dose-response study in young healthy men. Andrology 2018;6:64-73. [PMID: 29280355 DOI: 10.1111/andr.12454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Adams LK, Ferrington LS. New recommendations in prostate cancer screening and treatment. JAAPA 2014;27:14-20; quiz 26. [PMID: 24988136 DOI: 10.1097/01.JAA.0000451872.86566.bf] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Wilson RL, Taaffe DR, Newton RU, Hart NH, Lyons-Wall P, Galvão DA. Maintaining Weight Loss in Obese Men with Prostate Cancer Following a Supervised Exercise and Nutrition Program-A Pilot Study. Cancers (Basel) 2021;13:3411. [PMID: 34298627 DOI: 10.3390/cancers13143411] [Reference Citation Analysis]
7 Allan CA, Collins VR, Frydenberg M, Mclachlan RI, Matthiesson KL. Androgen deprivation therapy complications. Endocrine-Related Cancer 2014;21:T119-29. [DOI: 10.1530/erc-13-0467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
8 Samson N, Khanolkar RA, Quirk S, Quon H, Roumeliotis M, Balogh A, Sia M, Thind K, Husain S, Martell K. Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer. Curr Oncol 2021;28:3729-37. [PMID: 34677236 DOI: 10.3390/curroncol28050318] [Reference Citation Analysis]
9 Fairman CM, Kendall KL, Hart NH, Taaffe DR, Galvão DA, Newton RU. The potential therapeutic effects of creatine supplementation on body composition and muscle function in cancer. Crit Rev Oncol Hematol 2019;133:46-57. [PMID: 30661658 DOI: 10.1016/j.critrevonc.2018.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
10 Rhee H, Navaratnam A, Oleinikova I, Gilroy D, Scuderi Y, Heathcote P, Nguyen T, Wood S, Ho KKY. A Novel Liver-targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men With Prostate Cancer. J Endocr Soc 2021;5:bvab116. [PMID: 34308090 DOI: 10.1210/jendso/bvab116] [Reference Citation Analysis]
11 Nilsen TS, Thorsen L, Fosså SD, Wiig M, Kirkegaard C, Skovlund E, Benestad HB, Raastad T. Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy: Strength training and androgen deprivation. Scand J Med Sci Sports 2016;26:1026-35. [DOI: 10.1111/sms.12543] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
12 Light KC, Agarwal N, Iacob E, White AT, Kinney AY, VanHaitsma TA, Aizad H, Hughen RW, Bateman L, Light AR. Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. Psychoneuroendocrinology 2013;38:2983-95. [PMID: 24054763 DOI: 10.1016/j.psyneuen.2013.08.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
13 Cheung AS, Zajac JD, Grossmann M. Muscle and bone effects of androgen deprivation therapy: current and emerging therapies. Endocr Relat Cancer 2014;21:R371-94. [PMID: 25056176 DOI: 10.1530/ERC-14-0172] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
14 Lamboley CR, Xu H, Dutka TL, Hanson ED, Hayes A, Violet JA, Murphy RM, Lamb GD. Effect of androgen deprivation therapy on the contractile properties of type I and type II skeletal muscle fibres in men with non-metastatic prostate cancer. Clin Exp Pharmacol Physiol 2018;45:146-54. [DOI: 10.1111/1440-1681.12873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Wong CKH, Choi EPH, Tsu JHL, Ho BSH, Ng ATL, Chin WY, Yiu MK. Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer. Qual Life Res 2015;24:2397-402. [DOI: 10.1007/s11136-015-0993-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
16 Rana K, Lee NK, Zajac JD, MacLean HE. Expression of androgen receptor target genes in skeletal muscle. Asian J Androl 2014;16:675-83. [PMID: 24713826 DOI: 10.4103/1008-682X.122861] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Antoun S, Bayar A, Ileana E, Laplanche A, Fizazi K, di Palma M, Escudier B, Albiges L, Massard C, Loriot Y. High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting. European Journal of Cancer 2015;51:2570-7. [DOI: 10.1016/j.ejca.2015.07.042] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
18 Erden ES, Genc S, Motor S, Ustun I, Ulutas KT, Bilgic HK, Oktar S, Sungur S, Erem C, Gokce C. Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome. Endocrine 2014;45:311-8. [DOI: 10.1007/s12020-013-0022-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
19 Yunfeng G, Weiyang H, Xueyang H, Yilong H, Xin G. Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis. Medicine (Baltimore) 2017;96:e7368. [PMID: 28682886 DOI: 10.1097/MD.0000000000007368] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 5.6] [Reference Citation Analysis]
20 Cormie P, Zopf EM. Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer. Urologic Oncology: Seminars and Original Investigations 2020;38:62-70. [DOI: 10.1016/j.urolonc.2018.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
21 Handelsman DJ, Hirschberg AL, Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocr Rev 2018;39:803-29. [PMID: 30010735 DOI: 10.1210/er.2018-00020] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 31.0] [Reference Citation Analysis]
22 Basaria S. Time to raise awareness regarding complications of androgen deprivation therapy. Asian J Androl 2012;14:175-6. [PMID: 22367185 DOI: 10.1038/aja.2011.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Zimmer P, Jäger E, Bloch W, Zopf EM, Baumann FT. Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study. BMC Cancer 2013;13:272. [PMID: 23731674 DOI: 10.1186/1471-2407-13-272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
24 Kiwata JL, Dorff TB, Schroeder ET, Gross ME, Dieli-Conwright CM. A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients. Prostate Cancer Prostatic Dis 2016;19:323-32. [PMID: 27349496 DOI: 10.1038/pcan.2016.25] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Otto-Duessel M, Tew BY, Vonderfecht S, Moore R, Jones JO. Identification of neuron selective androgen receptor inhibitors. World J Biol Chem 2017; 8(2): 138-150 [PMID: 28588757 DOI: 10.4331/wjbc.v8.i2.138] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Nilsen TS, Johansen SH, Thorsen L, Fairman CM, Wisløff T, Raastad T. Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise? Int J Environ Res Public Health 2022;19:3820. [PMID: 35409505 DOI: 10.3390/ijerph19073820] [Reference Citation Analysis]
27 Kokorovic A, So AI, Serag H, French C, Hamilton RJ, Izard JP, Nayak JG, Pouliot F, Saad F, Shayegan B, Aprikian A, Rendon RA. Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies. Can Urol Assoc J 2021;15:E307-22. [PMID: 34127184 DOI: 10.5489/cuaj.7355] [Reference Citation Analysis]
28 Hanson ED, Stopforth CK, Alzer M, Carver J, Lucas AR, Whang YE, Milowsky MI, Bartlett DB, Harrison MR, Hayes A, Bitting RL, Deal AM, Hackney AC, Battaglini CL. Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer. Prostate Cancer Prostatic Dis 2021;24:725-32. [PMID: 33495569 DOI: 10.1038/s41391-020-00317-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Kloner RA, Carson C 3rd, Dobs A, Kopecky S, Mohler ER 3rd. Testosterone and Cardiovascular Disease. J Am Coll Cardiol 2016;67:545-57. [PMID: 26846952 DOI: 10.1016/j.jacc.2015.12.005] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 25.7] [Reference Citation Analysis]
30 Ussing A, Mikkelsen MK, Villumsen BR, Wejlgaard J, Bistrup PE, Birkefoss K, Bandholm T. Supervised exercise therapy compared with no exercise therapy to reverse debilitating effects of androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 2021. [PMID: 34489536 DOI: 10.1038/s41391-021-00450-0] [Reference Citation Analysis]
31 Lønbro S. The effect of progressive resistance training on lean body mass in post-treatment cancer patients - a systematic review. Radiother Oncol 2014;110:71-80. [PMID: 24060169 DOI: 10.1016/j.radonc.2013.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
32 Gaskin CJ, Fraser SF, Owen PJ, Craike M, Orellana L, Livingston PM. Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study. J Cancer Surviv 2016;10:972-80. [PMID: 27098346 DOI: 10.1007/s11764-016-0543-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
33 Keilani M, Hasenoehrl T, Baumann L, Ristl R, Schwarz M, Marhold M, Sedghi Komandj T, Crevenna R. Effects of resistance exercise in prostate cancer patients: a meta-analysis. Support Care Cancer 2017;25:2953-68. [PMID: 28600706 DOI: 10.1007/s00520-017-3771-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 9.4] [Reference Citation Analysis]
34 Fisher MI, Davies CC, Colon G, Geyer H, Pfalzer L. Oncology Section EDGE Task Force on Prostate Cancer Outcomes: A Systematic Review of Clinical Measures of Strength and Muscular Endurance: . Rehabilitation Oncology 2015;33:37-44. [DOI: 10.1097/01893697-201533020-00006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Skinner TL, Peeters GG, Croci I, Bell KR, Burton NW, Chambers SK, Bolam KA. Impact of a brief exercise program on the physical and psychosocial health of prostate cancer survivors: A pilot study. Asia Pac J Clin Oncol 2016;12:225-34. [PMID: 26923217 DOI: 10.1111/ajco.12474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Owen PJ, Daly RM, Livingston PM, Fraser SF. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update. Prostate Cancer Prostatic Dis 2017;20:137-45. [PMID: 28117386 DOI: 10.1038/pcan.2016.69] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
37 Davies CC, Colon G, Geyer H, Pfalzer L, Fisher MI. Oncology EDGE Task Force on Prostate Cancer Outcomes: A Systematic Review of Outcome Measures for Functional Mobility. Rehabilitation Oncology 2016;34:82-96. [DOI: 10.1097/01.reo.0000000000000029] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
38 Lam T, McLean M, Hayden A, Poljak A, Cheema B, Gurney H, Stone G, Bahl N, Reddy N, Shahidipour H, Birzniece V. A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy. Endocr Connect 2019;8:605-15. [PMID: 30991356 DOI: 10.1530/EC-19-0179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Owen PJ, Daly RM, Dalla Via J, Mundell NL, Livingston PM, Rantalainen T, Fraser SF. The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer. J Cachexia Sarcopenia Muscle 2019;10:1036-44. [PMID: 31067013 DOI: 10.1002/jcsm.12446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]